Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.4 is now displayed, replacing v3.5.3. This indicates a small system/template update and does not modify the study content or its outcomes.
    Difference
    0.1%
    Check dated 2026-05-15T02:12:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Deleted the related topics block that listed Prostate Cancer and MedlinePlus Genetics. The page will no longer display these related informational resources as part of the study record.
    Difference
    0.2%
    Check dated 2026-05-07T21:50:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Prostate cancer and a related topics section with a MedlinePlus Genetics link to broaden contextual resources, and updated the revision label from v3.5.2 to v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-30T15:43:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Removed the “Prostate cancer” related topics links, including the MedlinePlus Genetics section.
    Difference
    0.2%
    Check dated 2026-04-23T14:13:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Prostate cancer and MedlinePlus Genetics as related topics and updated the revision from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-16T10:18:49.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The 'Prostate cancer' topic and 'MedlinePlus Genetics' related topics were removed from the page, reducing contextual keywords and navigation cues for users.
    Difference
    0.2%
    Check dated 2026-04-09T08:05:49.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.